Home
Duchenne
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
Explore Trials
Active Studies
Trial Statistics
Search
Home
Duchenne
Duchenne MD
What is Duchenne?
Genetic Causes
Creatine Kinase (CK)
Genetic Testing
Prenatal Testing
Becker MD
DMD vs BMD
NSAA Assessment
Genetic
Genetic Counseling
Exon Check Tool
Dystrophin Gene
Genetic Variants
Exon Deletion
Duchenne Carriers
Nucleotides in DMD
Isoforms in DMD
Care Guidelines
Newly Diagnosed
Neuromuscular Team
Respiratory Devices
BiPAP Machine
Ankle Foot Orthosis
Rhabdomyolysis
Power Wheelchair
Traveling with DMD
Health Guidelines
Psychological Support in DMD
Nutrition in DMD
Nutraceuticals
Respiratory Health
Dental Health
Surgery & Anesthesia
Swallowing Difficulty
Steroids (Cortisone)
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
Explore Trials
Active Studies
Trial Statistics
More
Search
Home
Tags
BRAZIL
BRAZIL
Press Releases
Italfarmaco and Multicare Pharma Sign Exclusive Distribution Deal for Givinostat (Duvyzat), a DMD Treatment in Brazil
Press Releases
Brazil Suspends Use of ELEVIDYS (delandistrogene moxeparvovec)
Editorials
Our Call to Anvisa: All Brazilian Children Over 7 Should Receive Elevidys Gene Therapy
Editorials
Brazilian Children Over 7 and Their Families Demand Elevidys Gene Therapy from Anvisa
Press Releases
In Brazil, the Government is Expected to Implement a Risk-Sharing Model with Roche for ELEVIDYS
Press Releases
Elevidys Gene Therapy has Arrived in Brazil and Could Cost up to 20 Million Brazilian Reais
Research
What is Ataluren (Translarna)? What is Ataluren Used For?
Editorials
In Which Countries Is Elevidys Approved? Is Elevidys Approved In Europe?
Popular
Frequently Asked Questions About Elevidys Used for DMD
DMD Warrior
-
August 16, 2026
Must Read
Care Guidelines
Peak Flow Meter in Duchenne Muscular Dystrophy: Complete Respiratory Monitoring Guide
DMD
Becker Muscular Dystrophy (BMD): Symptoms, Causes, Treatments & Life Expectancy
Editorials
Elevidys Under Scrutiny: A Candid Interview with the Turkish Representative of DMDWarrioR on Cost, Effectiveness, and Ethics
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language
Close and do not switch language
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language